NEW YORK, NY
Allocation by class
Portfolio Concentration
Top 3 weight
86.6%
Top 10 weight
99.0%
Voting Authority Distribution
Total shares with voting rights: 13.94M
Full voting authority
13.94M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BRIDGEBIO PHARMA INCSOLE | COM | 4.59M | SH | $341.83M 72.48% | 4.59M | 0.00 | 0.00 |
MONTE ROSA THERAPEUTICS INCSOLE | COM | 1.56M | SH | $37.65M 7.98% | 1.56M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.32M | SH | $28.79M 6.10% | 1.32M | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 1.43M | SH | $20.27M 4.30% | 1.43M | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 568.92K | SH | $16.89M 3.58% | 568.92K | 0.00 | 0.00 |
BRIDGEBIO ONCOLOGY THERAPEUTSOLE | COM NEW | 1.02M | SH | $7.76M 1.64% | 1.02M | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 77.03K | SH | $4.24M 0.90% | 77.03K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 108K | SH | $3.97M 0.84% | 108K | 0.00 | 0.00 |
BIOMEA FUSION INCSOLE | COM | 2.05M | SH | $3.01M 0.64% | 2.05M | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 434.45K | SH | $2.30M 0.49% | 434.45K | 0.00 | 0.00 |
EUPRAXIA PHARMACEUTICALS INCSOLE | COM | 325K | SH | $2.15M 0.46% | 325K | 0.00 | 0.00 |
VTV THERAPEUTICS INCSOLE | CL A NEW | 50K | SH | $1.88M 0.40% | 50K | 0.00 | 0.00 |
MARKER THERAPEUTICS INCSOLE | COM NEW | 325.37K | SH | $478.3K 0.10% | 325.37K | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | COM CL A | 88.61K | SH | $404.0K 0.09% | 88.61K | 0.00 | 0.00 |